MXPA04004276A - Derivados de heteroarilo como lingandos superiores para el receptor de nociceptina orl-1. - Google Patents

Derivados de heteroarilo como lingandos superiores para el receptor de nociceptina orl-1.

Info

Publication number
MXPA04004276A
MXPA04004276A MXPA04004276A MXPA04004276A MXPA04004276A MX PA04004276 A MXPA04004276 A MX PA04004276A MX PA04004276 A MXPA04004276 A MX PA04004276A MX PA04004276 A MXPA04004276 A MX PA04004276A MX PA04004276 A MXPA04004276 A MX PA04004276A
Authority
MX
Mexico
Prior art keywords
heteroaryl derivatives
nociceptin receptor
receptor orl
ligands
superior
Prior art date
Application number
MXPA04004276A
Other languages
English (en)
Inventor
Ginny D Ho
Original Assignee
Schering Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Schering Corp filed Critical Schering Corp
Publication of MXPA04004276A publication Critical patent/MXPA04004276A/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D451/00—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof
    • C07D451/02—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof
    • C07D451/04—Heterocyclic compounds containing 8-azabicyclo [3.2.1] octane, 9-azabicyclo [3.3.1] nonane, or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane or granatane alkaloids, scopolamine; Cyclic acetals thereof containing not further condensed 8-azabicyclo [3.2.1] octane or 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring systems, e.g. tropane; Cyclic acetals thereof with hetero atoms directly attached in position 3 of the 8-azabicyclo [3.2.1] octane or in position 7 of the 3-oxa-9-azatricyclo [3.3.1.0<2,4>] nonane ring system
    • C07D451/06—Oxygen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/06—Antiasthmatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/10—Expectorants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P11/00—Drugs for disorders of the respiratory system
    • A61P11/14—Antitussive agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/04—Centrally acting analgesics, e.g. opioids
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/22—Anxiolytics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/24—Antidepressants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00—Drugs for disorders of the nervous system
    • A61P25/30—Drugs for disorders of the nervous system for treating abuse or dependence
    • A61P25/32—Alcohol-abuse
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Biomedical Technology (AREA)
  • Pain & Pain Management (AREA)
  • Addiction (AREA)
  • Psychiatry (AREA)
  • Immunology (AREA)
  • Rheumatology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Hydrogenated Pyridines (AREA)

Abstract

Se describe novedosos compuestos de la formula (I)Ver formulaEn la cual R es heteroarilo opcionalmente sustituido o (a); R1 es H o alquilo C1-C6 y R2 y R3 son- CH3, -OCH3 o halo; o una sal o solvato farmaceuticamente aceptable de los mismos, por lo tanto, composiciones farmaceuticas y el uso de dichos compuestos en el tratamiento del dolor, la ansiedad, la tos, el asma, la depresion y el abuso del alcohol.
MXPA04004276A 2001-11-07 2002-11-06 Derivados de heteroarilo como lingandos superiores para el receptor de nociceptina orl-1. MXPA04004276A (es)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US33328401P 2001-11-07 2001-11-07
PCT/US2002/035539 WO2003039469A2 (en) 2001-11-07 2002-11-06 Heteroaryl derivatives as superior ligands for nociceptin receptor orl-1

Publications (1)

Publication Number Publication Date
MXPA04004276A true MXPA04004276A (es) 2004-08-11

Family

ID=23302135

Family Applications (1)

Application Number Title Priority Date Filing Date
MXPA04004276A MXPA04004276A (es) 2001-11-07 2002-11-06 Derivados de heteroarilo como lingandos superiores para el receptor de nociceptina orl-1.

Country Status (27)

Country Link
US (1) US6727254B2 (es)
EP (1) EP1442036B1 (es)
JP (2) JP4246066B2 (es)
KR (1) KR100596261B1 (es)
CN (1) CN1252068C (es)
AR (1) AR037211A1 (es)
AT (1) ATE315566T1 (es)
BR (1) BR0213907A (es)
CA (1) CA2465871C (es)
CY (1) CY1105208T1 (es)
DE (1) DE60208724T2 (es)
DK (1) DK1442036T3 (es)
EC (1) ECSP045096A (es)
ES (1) ES2256590T3 (es)
HK (1) HK1063019A1 (es)
HU (1) HUP0402329A2 (es)
IL (2) IL161120A0 (es)
MX (1) MXPA04004276A (es)
MY (1) MY126268A (es)
NO (1) NO329026B1 (es)
NZ (1) NZ532088A (es)
PE (1) PE20030719A1 (es)
PL (1) PL370269A1 (es)
RU (1) RU2327698C2 (es)
TW (1) TWI317360B (es)
WO (1) WO2003039469A2 (es)
ZA (1) ZA200403404B (es)

Families Citing this family (13)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20040067950A1 (en) * 1998-07-27 2004-04-08 Schering-Plough Corporation High affinity ligands for nociceptin receptor ORL-1
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
US8729107B2 (en) * 2002-12-06 2014-05-20 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
AU2003298034B2 (en) 2002-12-06 2011-04-21 Purdue Research Foundation Pyridines for treating injured mammalian nerve tissue
WO2005089761A1 (en) * 2004-03-17 2005-09-29 Pfizer Limited Combination for treating inflammatory diseases
CA2580292A1 (en) * 2004-09-15 2006-03-23 Schering-Plough Ltd. Process for preparing substituted 8-azabicyclo[3.2.1] octan-3-ols
DE102005016460A1 (de) 2005-04-11 2006-10-19 Grünenthal GmbH Spriocyclische Cyclohexanderivate zur Behandlung von Substanzabhängigkeit
PE20071159A1 (es) * 2005-10-31 2007-11-30 Schering Corp Derivados de tropano 3-monosustituido como ligandos de receptores de nociceptina
DE102006046745A1 (de) * 2006-09-29 2008-04-03 Grünenthal GmbH Gemischte ORL1/µ-Agonisten zur Behandlung von Schmerz
BRPI0911031B8 (pt) * 2008-07-21 2021-05-25 Purdue Pharma Lp compostos de piperidina ligada do tipo quinoxalina substituídos e os usos destes
GB201004311D0 (en) 2010-03-15 2010-04-28 Proximagen Ltd New enzyme inhibitor compounds
GB201115853D0 (en) 2011-09-14 2011-10-26 Proximagen Ltd New enzyme inhibitor compounds
US9724340B2 (en) * 2015-07-31 2017-08-08 Attenua, Inc. Antitussive compositions and methods

Family Cites Families (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352707A (en) 1992-03-26 1994-10-04 Harbor Branch Oceanographic Institution, Inc. Method for treating airway congestion
US6262066B1 (en) * 1998-07-27 2001-07-17 Schering Corporation High affinity ligands for nociceptin receptor ORL-1
TW590268U (en) * 2000-08-08 2004-06-01 Wistron Corp Heat dissipating device

Also Published As

Publication number Publication date
MY126268A (en) 2006-09-29
DE60208724T2 (de) 2006-11-02
CA2465871C (en) 2009-01-20
TWI317360B (en) 2009-11-21
ZA200403404B (en) 2005-08-15
JP4246066B2 (ja) 2009-04-02
ES2256590T3 (es) 2006-07-16
JP2005508367A (ja) 2005-03-31
EP1442036B1 (en) 2006-01-11
CN1582288A (zh) 2005-02-16
KR20050043725A (ko) 2005-05-11
PE20030719A1 (es) 2003-08-28
IL161120A (en) 2010-11-30
JP2009035556A (ja) 2009-02-19
IL161120A0 (en) 2004-08-31
RU2327698C2 (ru) 2008-06-27
BR0213907A (pt) 2004-09-28
EP1442036A2 (en) 2004-08-04
NO20042294L (no) 2004-07-15
HUP0402329A2 (hu) 2005-02-28
HK1063019A1 (en) 2004-12-10
CN1252068C (zh) 2006-04-19
DE60208724D1 (de) 2006-04-06
PL370269A1 (en) 2005-05-16
ATE315566T1 (de) 2006-02-15
TW200301765A (en) 2003-07-16
CA2465871A1 (en) 2003-05-15
WO2003039469A2 (en) 2003-05-15
CY1105208T1 (el) 2010-03-03
KR100596261B1 (ko) 2006-06-30
NZ532088A (en) 2006-05-26
WO2003039469A3 (en) 2003-10-16
AR037211A1 (es) 2004-10-27
NO329026B1 (no) 2010-08-02
RU2004117542A (ru) 2006-01-10
DK1442036T3 (da) 2006-05-15
ECSP045096A (es) 2004-06-28
US20030119847A1 (en) 2003-06-26
US6727254B2 (en) 2004-04-27

Similar Documents

Publication Publication Date Title
CY1105208T1 (el) Ετepοαρυλ παραγωγα σαν ανωτepοι συνδετηρες για τον υποδοχεα nociceptin orl-1
GB0004888D0 (en) Chemical compounds
MY134017A (en) Mch antagonists and their use in the treatment of obesity
MY140505A (en) High affinity ligands for nociceptin receptor orl-1
AP1965A (en) Tropane derivatives useful in therapy.
GEP20063958B (en) 1-alkyl-1-azoniabicyclo [2.2.2] octane carbamate derivatives and their use as muscarinic receptor antagonists
WO2005018557A3 (en) Substituted pyridinones
TW200745111A (en) New compounds
ATE450533T1 (de) Carboxamidderivate
MY130803A (en) New quinuclidine amide derivatives
MXPA06000716A (es) Derivados de quinolina y quinazolina que tienen afinidad hacia receptores del tipo 5ht1.
WO2001064639A3 (en) Pde iv inhibiting amides, compositions and pharmaceutical use
GEP20094605B (en) Pyrazole derivatives, compositions containing such compounds and methods of use thereof
WO2000066614A8 (en) 3α-HYDROXY-3β METHOXYMETHYL-21-HETEROCYCLE SUBSTITUTED STEROIDS WITH ANESTHETIC ACTIVITY
WO2004100865A3 (en) New benzimidazole derivatives
AU2003294142A1 (en) Therapeutic quinazoline derivatives
GB0109122D0 (en) Novel compounds
NO20082443L (no) 3-monosubstituerte tropanderivater som nociceptinreseptorligandere
MXPA04005484A (es) Procedimiento de preparacion de derivados de equinocandina.
MXPA03001356A (es) Nuevos agentes inhibidores de beta-amiloides, procedimientos para su preparacion y su uso como medicamentos.
MXPA03010321A (es) Derivados de 1-oxa-3,9-diaza-spiro-5,5-undecan-2-onas y su uso como antagonista del receptor de neurocinina.
CA2399818A1 (en) Preventive and therapeutic medicament for gastroesophageal reflux disease
SE0102057D0 (sv) New Salts I
AU2001296699A1 (en) Condensed pyrazindione derivatives as pde inhibitors
SE0301371D0 (sv) New Compounds

Legal Events

Date Code Title Description
FG Grant or registration